Table 4.
Variable | Univariable | Multivariable | |||
---|---|---|---|---|---|
| |||||
Comparison | Hazard ratio | p | Hazard ratio | p | |
Surgical approach | Open vs. robotic | 1.2 (0.74–1.8) | 0.53 | 0.8 (0.5–1.3) | 0.44 |
Preoperative PSA (per ng/ml) | N/A | 1.1 (1.0–1.1) | <0.0001 | 1.1 (1.0–1.1) | <0.0001 |
Gleason score | 3+3 vs. 3+4 | Not estimable | Not estimable | ||
4+3 vs. 3+4 | 3.6 (2.1–5.9) | <0.0001 | 2.7 (1.6–4.6) | 0.0004 | |
≥8 vs. 3+4 | 7.8 (4.3–14.2) | <0.0001 | 5.5 (2.9–10.4) | <0.0001 | |
Pathological stage | T3 vs. T2 | 5.6 (3.3–9.6) | <0.0001 | 3.0 (1.7–5.3) | 0.0002 |
PSA: prostate-specific antigen.